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Several polymorphisms in the CYP1A1 locus have been identified and their genotypes appear to exhibit 
population frequencies that depend on ethnicity. In this study, we assessed the role of CYP1A1 
genotype in 388 head and neck cancer patients in Pakistani population via a case-control study. 
Polymerase chain reaction (PCR) and single stranded conformational polymorphism assays were used. 
Most of the patients (51%) enrolled for the study, were from the age group of 40 to 60 years (±16.59). 
Mean age of the cancer patients involved in the study was 48 ± 16.59 years. Statistical analysis has 
shown that, tobacco users have more chances of head and neck cancer (P < 0.05) than non tobacco 
users, whereas male to female ratio is 1:1 (P > 0.05). Jobless persons are more prone to head and neck 
cancer (P < 0.01) compared with employers and housewives. After the genetic analysis, it was found 
that no already reported variants of CYP1A1 gene were found in Pakistani population. A novel mutation 
in CYP1A1 gene at exon 2 in 21 patients (P < 0.001, Odd Ratio (OR) = 9.4 and 95% confidence interval 
(CI) 1.3 to 70.8) has been found with a serine formation instead of tyrosine at amino acid 110. The 
patients showing this mutation have the mean age of 51.75 (±15.7). Therefore, mutation in CYP1A1 gene 
may be one of several factors that increase the chance of developing head and neck cancer.  
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Head and neck cancer (HNC) includes the cancers of 
oral cavity, larynx and pharynx and is the sixth most 
frequent cancer worldwide and is particularly, high in 
south East Asian countries (Johnson 1991; Parkin et al., 
2002). In Pakistan, incidence of head and neck cancer is 
40.1% of all the cancers (Hanif et al., 2009) and the 
second most frequent type of prevalent cancers 
(Faheem, 2007). In France, cancer of pharynx is more 
common in men, while cancer of oral cavity is more 
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(Makimoto et al., 2000) marked rise in incidence of HNC 
has been reported in last few decades 
(Sankaranarayanan et al., 1998; Morelatto and Lopez, 
2006).  
Multitudes of factors are responsible for occurrence of 
HNC like lifestyle, dietary habits and mental stress 
(Jensen et al., 2010). Workers of mines and nickel or 
wood industry are more prone to HNC (Tevfik et al., 
2007). Environmental factors like chewing tobacco and 
alcohol are given special attention in relation to head and 
neck cancer (Sabitha et al., 2010). Exposure to synthetic 
or natural chemical compounds present in the environ-
ment is usually associated with HNC. Xenobiotics 
metabolizing enzymes are responsible for metabolism of 
many exogenous chemicals that are toxic, mutagenic or 
carcinogenic. Carcinogen detoxifying enzymes include 
the phase I enzymes involved in the detoxification of 
carcinogens and either neutralize them or change them 
into electrophilic compounds that are detoxified by the 
phase II enzymes (Rajani et al., 2003).  




The principal enzymes responsible for phase I reaction 
belong to cytochrome P-450 multigene family. The 
cytochrome P450 1A1 enzyme functions by the addition 
of oxygen atom into the toxic chemical and initiate 
detoxification and elimination by increasing hydrophilicity 
(Guengerich and Shimada 1991). Cytochrome P450 1A1 
gene (CYP1A1) is located on chromosome 15q22-24 and 
encodes aromatic hydrocarbon, hydroxylase that 
converts polycyclic aromatic hydrocarbons (PAHs) 
(Shimada et al., 1989) to carcinogen and is predomi-
nantly expressed in extrahepatic tissues including lungs 
(Anttila et al., 1992).  
The cytochrome P-450 that are known to exhibit 
polymorphism include CYP1A1, CYP1B1 (Arrind et al., 
2008), CYP2A6, CYP2C9, CYP2C19, CYP2D6 and 
CYP2E1 (Rajani et al., 2003). Polymorphism of CYP1A1 
gene has been studied with relation to different cancers 
including head and neck cancer (Sabitha et al., 2010). 
Four different sequence polymorphisms have been 
reported in CYP1A1 gene, first known as CYP1A1*2 
involves a T6235 to C transition in the 3’ noncoding region 
(Kawajiri et al., 1990; Jun et al., 2010), second known as 
CYP1A1*3 involve a A4889 to G transition in exon 7 (Jun et 
al., 2010; Hayashi et al., 1991), third known as 
CYP1A1*4 involves a T5639 to C transition in intron 7 
(Crofts et al., 1993) and fourth known as CYP1A1*5 
involves a C4887 to A transition in exon 7 (Jun et al., 2010; 
Cascorbi et al., 1996). The present study is aimed at 
evaluating the role of environmental factors in head and 
neck cancer risk along with CYP1A1 gene 
polymorphisms in Pakistani population.  
 
 
MATERIALS AND METHODS 
 
Identification of patients and normal controls 
 
The present case-control study consisted of 388 cases with 
pathologically confirmed head and neck cancer along with age and 
sex matched 150 cancer free normal individuals as controls. They 
were recruited from National Oncology and Radiotherapy Institute 
(NORI) and Pakistan Institute of Medical Sciences (PIMS), 
Islamabad from March 2008 to September 2009 with a prior 
approval from Ethical Committees of both university and hospitals.  
All study subjects participated on a volunteer basis. All subjects 
were personally interviewed according to a structured question-
naire. They were asked about area of cancer, age, tobacco 
addictions and occupational exposures. Blood was collected from 
subjects with their informed consent. Information concerning 
alcohol intake was found fairly unreliable and was disregarded due 
to Muslim community. However, our experiences with patients and 
control blood donors have shown that, majority are tobacco 
addicted in the form of betel quids and moist snuff. Subjects’ blood 
was sampled before starting the therapy. 
 
 
Sample collection and DNA isolation  
 
Blood samples were collected in EDTA-containing tubes and stored 
at -20°C until further use. DNA was isolated, using organic protocol 
with phenol-chloroform extraction as previously described 





Electrophoresis was performed on isolated DNA on 1% ethidium-
bromide stained agarose gel and photographed (BioDocAnalyze 
Biometra). 5 ng dilutions were made of each DNA isolated and 
stored at 4°C until use. 
 
 
Primer designing and polymerase chain reaction (PCR) 
 
Primers for 7 exons of CYP1A1 were synthesized by using primer 3 
input software version 0.4.0 (Table 1) and BLAST using NCBI 
PRIMER BLAST. 2 µl DNA (10 ng/µl) was added to a 20 µl PCR 
mixture composed of 2 µl PCR buffer, 2 µl of each primer (10 mM), 
0.24 µl deoxynucleotide triphosphate (25 mM) and 0.2 µl Taq 
polymerase (5 u/µl). The reaction mixture was placed in 9700 
thermal cycler of ABI systems for 5 min at 94°C and subjected to 30 
cycles at 94°C for 25 s, annealing temperature for 1 min and 72°C 
for 1 min, followed by a final step at 72°C for 10 min and held at 
4°C. 
Amplification products were resolved on a 2% ethidium bromide-
stained agarose gel along with 100 bp DNA ladder. All the patients 
and control DNA was amplified for all the 7 exons of CYP1A1 gene 
with exon specific primers. All of the photographs of gel 




Single strand conformational polymorphism 
 
PCR product was analyzed by single stranded conformational 
polymorphism (SSCP) using the procedure described by Patricia et 
al. (2009) and Amalio et al. (1993) with some minor modifications. 
SSCP results were analyzed with gel documentation system 
(BioDocAnalyze Biometra) after ethidium bromide staining and 
photographed. The samples showing mobility shifts from the 





21 samples were screened out from SSCP and were sequenced 
from Macrogen (Korea). Reverse primer was used for sequencing. 
The sequenced results were made forward complementary before 
analysis using BioEdit v 7.0.5 software and analyzed. Statistical 
analysis was performed by using SPSS statistics 17.0 software and 
GraphPad Prism 5 Demo for calculating odd ratios, 95% confidence 





Highly significant difference in number of patient with 
cancer of oral cavity (P < 0.01) was found compared with 
pharyngeal and laryngeal cancers. In cancer of oral 
cavity, pharynx and larynx, difference in number of male 
patients compared with females was statistically non 
significant (P > 0.05).    
Statistically significant increase in incidence of head 
and neck cancer was observed in age group of 40 to 60 
years (P < 0.05). The mean age of cancer patients was 
48 years (±16.59), whereas the mean age of controls was 
46 (±17.69) years. A higher number of males had 
cancers of oral cavity and laryngeal cancer, whereas 
females had a higher frequency of pharyngeal cancer 
cases as shown  in  Figure  1.  Surprisingly  no  statistical  




Table 1. Primer sequences synthesized for different exons of 
CYP1A1. 
 
Primer name Primer sequence 
CYP1A1 Exon1 Forward TACAGGCACCGAGATGTGTC 
CYP1A1 Exon1 Reverse AGTCCTGGAGGCACCAAAAT 
  
CYP1A1 Exon2a Forward GTTTCCCCTTTCCCTGACAC 
CYP1A1 Exon2a Reverse CAGGTAGCAGGAGGTTGAGG 
  
CYP1A1 Exon2b Forward CCGACCTCTACACCTTCACC 
CYP1A1 Exon2b Reverse CCCATGCAGTTCCTCTTACC 
  
CYP1A1 Exon3 Forward GACCAGACCTGGATGGAGAG 
CYP1A1 Exon3 Reverse TGACTGTGTCAAACCCTGGA 
  
CYP1A1 Exon4 Forward TGTGTCCTTCCTGTGCTCAA 
CYP1A1 Exon4 Reverse AACACAGGGACAAGATGGATG 
  
CYP1A1 Exon5 Forward AGGTAGTGGCTCCCTTCAAA 
CYP1A1 Exon5 Reverse TGTCCCTCCCACTAACCCTA 
  
CYP1A1 Exon6 Forward GACACGGCATGGGAGACA 
CYP1A1 Exon6 Reverse ATGGACAGGAGGATCAATGC 
  
CYP1A1 Exon7a Forward GCATTGATCCTCCTGTCCAT 
CYP1A1 Exon7a Reverse CAGAGGCAAGTCCAGGGTAG 
  
CYP1A1 Exon7b Forward TGTCTACCTGGTCTGGTTGG 
CYP1A1 Exon7b Reverse CCTCCAGGACAGCAATAAGG 
  
CYP1A1 Exon7c Forward CTGCCAAGAGTGAAGGGAAG 
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Figure 1. Frequency of head and neck cancer cases with reference to age bands, area of cancer and sex. 
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variations, with respect to gender were observed (P > 
0.05) and male to female ratio was found to be 1:1 
(Figure 1). 
 This study shows that persons using any form of 
tobacco (cigarettes, cigars, bidhi, moist snuff) and betel 
nuts are more affected by HNC (P < 0.05) compared with 
nontobacco users (Figure 2). In tobacco addicted 
patients, highest number of oral cancer cases were 
present (66%) compared with pharyngeal (24%) and 
laryngeal (10%) cancers.  
In jobless persons, a statistically significant increase (P 
< 0.01) in incidence of head and neck cancer was found 
compared with housewives, businessman and labors. A 
lower incidence of head and neck cancer was observed 
in businessman and office employers (14%) when 
compared with labors (17%) and housewives (20%) 
shown in Figure 3.  
Figure 4 shows that, no polymorphism in either of the 
reported variants CYP1A1*2, CYP1A1*3, CYP1A1*4 and 
CYP1A1*5 has been observed in this study consisting of 
388 head and neck cancer cases and 150 controls. A 
novel substitution mutation of A2842 with C (Figure 5 and 
Table 2) was observed in 21 patients (P < 0.001, odd 
ratio (OR) = 9.4 and 95% confidence interval (CI) 1.3 to 
70.8), whereas no control showed this mutation in exon 
2. This A2842 to C mutation causes a change in DNA 
sequence from TAC to TCC and resulting UCC which 
codes serine, whereas wild type UAC codes for tyrosine. 
This tyrosine to serine mutation is in the conserved P450 
domain and not in the transmembrane domain. In 21 
patients with CYP1A1 mutation in 2nd exon, 62% are 
female (OR 1.6, 95% CI 0.09 to 29.8) and 38% are males 
(OR 0.6, 95% CI 0.03 to 11.3), while 76% have cancer of 
oral cavity, 14% of pharynx and 10% of laryngeal cancer 
(OR 3.2, 0.17 and 0.11, respectively). The mean age of 
patients, showing A to C substitution mutation, was 51 ± 
15.7 years. This mutation was present in more patients 
with a job (OR 0.75, 95% CI 0.04 to 13.7) when 
compared with jobless (OR 0.62, 95% CI 0.03 to 11.3) 





The main aim of this case control study was to evaluate 
the key risk factors for head and neck cancer (HNC). The 
current study clearly demonstrates that, environmental 
factors along with genetic polymorphism of CYP1A1 gene 
are the main cause of head and neck cancer. Oral cavity 
cancer is the most prevalent area of head and neck 
cancer followed by pharynx and then larynx in our data. 
These findings are in accordance with the previous 
findings by Llewellyn et al. (2004), Shiboski et al. (2000) 
and Ping et al. (2007) differing only in increased 
incidence of HNC. In Americans and Caucasians, 
incidence of oral cancer has increased in the past few 
years; however, pharyngeal cancer is not common in 
most of the world populations (Parkin et al., 2002). 
The mean age of our study patients was 48 years and 
highest HNC cases were observed in age group of 40 to 
60 years. The age is an uncontrollable variable with the 
increase in age particularly between 40 to 60 years the 
risk of head and neck cancer is increased 
(Shanmugaratnam et al., 1982). This study reveals that, 
age more than 45 years should be considered as a risk 
factor for HNC development as found in earlier studies 
(Llewellyn et al., 2004) and once HNC is developed, the 
survival, particularly >80 years of age, is reduced when 
compared with patients <65 years age (Clayman et al., 
1998). Mean age of pharyngeal cancer patients in South 
East Asia is lower compared with Western countries (Yu 
and Yuan, 2002).  
In the present study, 50% were males and equal 
females. This shows that the males and females are 
equally affected by head and neck cancer. This finding is 
in contrast with  the  findings  from  earlier  studies  which  
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Figure 4. (A) No mobility shift in exon 7 CYP1A1 gene of patients and normal controls in ethidium bromide stained PAGE; (B) no 




reported a 2:1 male to female ratio (Toefil et al., 2007) 
and that of Abdulamir et al. (2008) who found no 
association of age with sex ratio and areas of head and 
neck cancer in Asian patients.  
The smoking status is always expected to be a key risk 
factor in development of cancer of any origin particularly 
HNC. In this study, 63.79% were smokers and 36.21% 
were non-smokers. The P value with Fishers exact test is 
(P < 0.05) which show that incidence of HNC in smokers 
is approximately two fold compared with non-smokers. 
Such results have frequently been reported in other parts 
of the world (Jun et al., 2010; Hecht et al., 1993). A study 
in the USA have shown that, heavy smokers die due to 
carcinoma of larynx 32 folds earlier than age-adjusted 
non-smokers and of oral cavity cancer, more than 24 
folds  earlier  compared  with  non-smokers  (Berrino  and 








Figure 5. (A) Difference in mobility of exon 2, CYP1A1 gene, between patients and normal 
controls in ethidium bromide stained PAGE; (B) G instead of T in sequencing compared with 




Table 2. Statistical data of patients having CYP1A1 exon 2 mutation at 
aminoacid 110. 
 
Variable A to C mutation OR (CI 95%) P value 
Total patient 21 9.4 (1.3 to 70.8) 0.007 
Gender    
Female 62% 1.6 (0.09- 29.8) 0.4 
Male 38% 0.6 (0.03-11.3) 0.4 
Age    
Mean 51.75 (±15.7)  
<48 52% 1.1 (0.06- 20.0) 1 
>48 48% 0.9 (0.05- 16.5) 1 
    
Smoking    
Yes 62% 1.6 (0.09- 29.8) 0.4 
No 38% 0.6 (0.03-11.3) 0.4 
    
Occupation    
Job 9 0.75 (0.04- 13.7) 1 
Jobless 8 0.62 (0.03- 11.3) 1 
house wives 4 0.2 (0.01- 4.62) 1 
    
Area of cancer    
Oral Cavity 76% 3.2 (0.17- 61.02) 0.03 
Pharynx 14% 0.17 (0.01- 3.4) 1 





Gatta, 1998). These findings are also in agreement with 
earlier studies (Eaden et al., 2000; Lee et al., 2004; 
Llewellyn et al., 2004) in different populations where it 
has been established that, smoking plays a significant 
role in pathogenesis of HNC.  
Interestingly, HNC is more common in jobless indivi-
duals due to increased tobacco addictions and mental 
stress when compared with on job individuals. This might 
be the reason that, house wives have least percentage of 
head and neck cancer (Abdulamir et al., 2008). Increased 
incidence of HNC in jobless individuals may also be 
attributed to increased mental stress (Jensen et al., 2010) 
as in Pakistan it has increased significantly (Pope et al., 
1983; Bhugra, 2004). The results suggested that, the 
occurrence of head and neck cancer (HNC) is related to 
age, smoking and the occupation status.  
CYP1A1 is involved in the activation of many polycyclic 
aromatic hydrocarbon and aromatic amines by enzyme 
aryl hydrocarbon hydrolase (Bartsch et al., 2000). In the 
present case-control study, none of the already reported 
mutations were observed. However, a novel mutation in 
exon 2 of CYP1A1 gene was observed which causes 
tyrosine to change in serine at amino acid number 110 of 
CYP1A1 gene. Tyrosine to serine substitution mutation 
causes a change in conserved domain of cytochrome 
P450. This mutation cause, a change in the protein 
structure as an aromatic amino acid is changed into a 
non aromatic amino acid and subsequently, gene 
function is also altered. Aside from being a proteogenic 
amino acid, tyrosine has a special role by virtue of the 
phenol functionality. It occurs in proteins that are part of 
signal transduction processes. Tyrosine is a precursor to 
neurotransmitters and increases plasma neurotransmitter 
levels (particularly dopamine and norepinephrine). There-
fore, this mutation might lead to imbalanced functional 
activity in detoxification process as CYP1A1 is a key 
enzyme that converts PAHs into active carcinogens 
(Hecht et al., 1993; Bartsch et al., 2000). PAHs present in 
tobacco smoke activate transcription of the CYP1A1 gene 
and increase pulmonary CYP1A1 activity several fold 
(Omiecinski et al., 1990). Mutated CYP1A1 gene can not 
convert carcinogen into a hydrophilized form required for 
phase II enzyme activation (glutathione-S-transferase 
isozymes GSTM1, GSTP1 and GSTT1) for the process of 
detoxification.  
The current mutation of CYP1A1 gene along with 
environmental factors may be one of the several factors 
causing head and neck cancer. Polymorphisms in 
CYP1A1 gene and alterations in their expression and 
function, may increase or decrease carcinogen activation/ 
detoxification followed by a variation of cancer risk (Shen 
et al., 2002; Jourenkova et al., 1998; Olshan et al., 2000; 
Lea et al., 2007; Matullo et al., 2001; Park et al., 2002). 
However, the ultimate phenotypic effect reflects a 
complicated network of interactions between genes and 
environmental factors. This study focuses on only one 
gene CYP1A1 with environmental  factors  in  HNC; how- 




ever, determining the role of genetic polymorphisms as 
cancer risk factor would require studies aiming at the 
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